Clinical Trial

Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of Thrombocytopenia

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated August 20, 2024 (before its estimated January 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is an investigator-initiated, single-arm, prospective clinical study to evaluate the efficacy and safety of heptapopal in the treatment of thrombocytopenia prior to elective surgery
Trial Details
NCT Number NCT06562738
Lead Sponsor The Third People's Hospital of Chengdu
Collaborators: Affiliated Hospital of North Sichuan Medical College
Conditions Thrombocytopenia
Enrollment 55 participants
Start Date 2024-06-01
Primary Completion 2025-01-31 (estimated)
Study Completion 2025-03-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-20